Digital repository of Slovenian research organisations

Show document
A+ | A- | SLO | ENG

Title:Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : an initiative of the Central European Cooperative Oncology Group (CECOG)
Authors:ID Thallinger, Christiane (Author)
ID Berzinec, Peter (Author)
ID Bicakcic, Emina (Author)
ID Dan, Adelina (Author)
ID Fabian, Gabriella (Author)
ID Gales, Laurentia Nicoletta (Author)
ID Grašič-Kuhar, Cvetka, Onkološki inštitut (Author)
ID Janžič, Urška, Klinika Golnik (Author)
ID Mencinger, Marina, Onkološki inštitut (Author)
ID Zielinski, Christoph (Author)
Files:.pdf PDF - Presentation file, download (1,14 MB)
MD5: F6D526A31B618E9D49B935C799F7E617
 
URL URL - Source URL, visit https://link.springer.com/content/pdf/10.1007/s00508-022-02016-z.pdf
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKPBAG - University Clinic of Respiratory and Allergic Diseases Golnik
Abstract:o establish a transborder virtual tumor board (VTB) fostering state-of-the-art management of cancer patients by exchanging knowledge and expertise among oncologists in Central and Southeastern Europe (CEE). Methods: We established and implemented a VTB based on the WebEx platform. This allowed for password-protected and secure upload of patient cases to be presented and discussed among colleagues from various oncology centers scattered throughout CEE in order to arrive at a recommendation for further diagnoses and/or treatment. Results: A total of 73 cases from 16 oncology centers located in 11 CEE countries were uploaded by 22 physicians; 71 were discussed over the course of 17 virtual meetings between June 2018 and May 2019 and 12 different kinds of malignant diseases were discussed with lung cancer (46.6%), melanoma (19.2%) and bladder cancer (13.6%) being the most commonly presented tumor entities. Of the discussed patients, 93.3% had stage IV disease at the time of presentation, 62.6% received chemotherapy or targeted treatment and 67.1% were treated with immune checkpoint inhibitors (ICPIs). The most common causes for presentation and discussion of patient cases were related to the use of ICPIs (80%). Conclusion: When the need for expertise exceeds locally available resources, web-based VTBs provide a feasible way to discuss patient cases and arrive at conclusions regarding diagnoses and/or treatment across large geographic distances. Moreover, VTBs provide an innovative way for proper, state-of-the-art management of patients with malignant diseases in times of social distancing and the resulting need for restricted interaction during the current SARS-CoV‑2 (severe acute respiratory syndrome coronavirus type 2) pandemic.
Keywords:CECOG, Osrednja in jugovzhodna Evropa, nadzorni imunski zaviralci, maligne bolezni
Year of publishing:2022
Publication status in journal:In print
Article version:Publisher's version of article
Publisher:Springer Nature
Number of pages:str. [1-8]
Numbering:Vol. , no.
Source:Avstrija
UDC:616-006
ISSN on article:0043-5325
DOI:10.1007/s00508-022-02016-z New window
COBISS.SI-ID:102525955 New window
Copyright:© The Author(s)
Note:Soavtorice iz Slovenije: Cvetka Grašič Kuhar, Marina Mencinger, Urška Janžič;
Publication date in DiRROS:31.03.2022
Views:183
Downloads:109
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
  
Share:AddThis
AddThis uses cookies that require your consent. Edit consent...

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Wiener Klinische Wochenschrift
Shortened title:Wien. Klin. Wochenschr.
Publisher:Springer
ISSN:0043-5325
COBISS.SI-ID:5473799 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:15.02.2022

Secondary language

Language:Undetermined
Keywords:CECOG, Central and Southeastern Europe, immune checkpoint inhibitors, malignant diseases


Back